The Therapeutic Products Division (TPD) is responsible for the registration of medicines and the continual review of approved medicinal products. TPD will facilitate the timely introduction and availability of new and innovative quality medicines in Singapore and the region, including medicines targeted for diseases prevalent in the region. |
The main activities relating to the control of medicinal products include:
- Evaluation and approval of applications for new product licences, amendment and renewal of existing product licences, as well as the continual review of registered medicinal products.
- Evaluation and approval for import of unregistered medicinal products on a named patient basis.
- Approval for the import of medicinal products for the purpose of re-export.
- Evaluation and approval of applications for licences for the purpose of importation of registered medicinal products on a per consignment basis.
- Evaluation, approval and monitoring of clinical trials on medicinal products.
- Secretariat support for the Medicines Advisory Committee (MAC) and the Medical Clinical Research Committee (MCRC).
|
|
|
|
|
|
|